Saia John G. 4

What Happened

• John G. Saia, Chief Legal Officer of Guardant Health, received an award of 20,448 restricted stock units (RSUs) on March 11, 2026. The grant is reported as an acquisition (award) at $0.00 per share (derivative award), meaning no cash was paid for the shares when granted.

Key Details

• Transaction date: March 11, 2026; Form 4 filed March 13, 2026 (appears timely).
• Transaction code: A (award/grant); reported price: $0.00.
• Vesting: 33% vests on April 1, 2027; remaining 67% vests in equal quarterly installments over the subsequent two years (three-year total vesting schedule). (Footnote F1)
• Footnote F2: "Not applicable for Restricted Stock Units." (as noted in the filing)
• Shares owned after the transaction: not disclosed in the provided filing details.

Context

• This was a compensation award (RSUs), not a market purchase or sale, so it reflects a grant of future shares tied to a vesting schedule rather than an immediate buy or sell. RSUs typically convert to shares upon vesting and are usually taxable as ordinary income at that time. The filing shows the grant was reported promptly.